Clinical Trials Directory

Trials / Conditions / Stage IV Bladder Urothelial Carcinoma AJCC v7

Stage IV Bladder Urothelial Carcinoma AJCC v7

8 registered clinical trials studyying Stage IV Bladder Urothelial Carcinoma AJCC v7 — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingTesting the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Sur
NCT05987241
National Cancer Institute (NCI)Phase 2 / Phase 3
CompletedNivolumab and RT in Treating Patients With Localized/Locally Advanced Urothelial Bladder Cancer Ineligible for
NCT03421652
Barbara Ann Karmanos Cancer InstitutePhase 2
Active Not RecruitingSapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mut
NCT03047213
National Cancer Institute (NCI)Phase 2
CompletedCisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Uroth
NCT02567409
National Cancer Institute (NCI)Phase 2
CompletedGemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or C
NCT02178241
National Cancer Institute (NCI)Phase 2
RecruitingCollecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate o
NCT01050504
University of Washington—
CompletedGemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary
NCT00942331
National Cancer Institute (NCI)Phase 3
Active Not RecruitingEribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney
NCT00365157
National Cancer Institute (NCI)Phase 1 / Phase 2